News

The payment was made in connection with Boehringer‘s decision for executing the development of lead Nanobody candidate targeting Alzheimer’s disease. Earlier, the research and licensing pact was signed

Votubia tablets are indicated as a treatment for children and adults suffering from subependymal giant cell astrocytoma (SEGA) or brain tumors linked with tuberous sclerosis complex (TSC). The

Inavir is the first of a new class of long acting neuraminidase inhibitors (LANIs) designed to address the limitation of the current influenza anti-virals, which require daily or

The company will evaluate around 20 patients with type 1 diabetes in the Phase IIa trial. The results from a Phase I trial demonstrated that the action of

CNX-011-67, a potent and selective GPR40 agonist, is a small molecule candidate that acts on the pancreatic beta cells and enhances glucose sensitivity, insulin secretion and reduce metabolic

The company expects to roll out AccuDial Children’s pain and fever medications with acetaminophen in five flavors: cherry, dye-free cherry, bubblegum, strawberry, and grape in the US. BroadMed

Remoxy, which is based on Durect’s Oradur technology, is an experimental drug that is a controlled release formulation of oxycodone for moderate-to-severe chronic pain designed to reduce potential

BioThrax is indicated to prevent anthrax infection and is also indicated for the active immunization of adults who are at high risk of exposure to anthrax. BioThrax is

The pRED French R&D Institute will be managed by a Roche academic team which will be in charge of building new research networks with French academic partners, leveraging